General Info

Dyadic International is a publicly held biotechnology company. It serves the chemical, agriculture, diagnostics, biofuels, health, beauty care, and pulp and paper industries. The company provides solutions for the manufacturing of plastics, butanol, chemical intermediates, polymers, resins, vitamins and compounds. Founded in 1979, Dyadic International is engaged in the development, manufacture and sale of biological products. The company focuses on a system for protein production that is based on the patented Chrysosporium lucknowense fungus, known as C1. It sells more than 50 liquid and dry enzyme products to customers in over 45 countries. The company also licenses its patents and platforms to business collaborators.